Summary The relationship between tumorigenicity and expression of MHC class II molecules in a class IInegative murine leukaemia cell line (LBC) was studied. Analysis of structural DNA sequences encoding MHC class II proteins was performed by Southern blot with DNA isolated from both the original LB tumour and LBC cell line, digested with EcoRI, BamHI and HindlIl and hybridised with specific probes for I-Acd and IAftd chains. Similar patterns were obtained for LB, LBC and normal BALB/c lymphocytes. In vitro treatment with IFN-y (20-1000 IU ml-') failed to induce the expression of MHC class II antigens in LBC cell line. LBC cells were tri-transfected by a liposome-mediated protocol with I-Aocd, I-Afd genes and pSV2neo. Cells were selected for growth in medium containing Geneticin (G418). Surviving transfectants were cloned and three I-A' clones were obtained after 20 days (LBCT cells). Syngeneic mice inoculated with 1.0 x 103 LBCT (I-A+) cells failed to develop a tumour, whereas the DT50 of mice injected with 1.0 x 106 LBCT cells was three times the value for mice injected with LBC cells (I-A-) . Furthermore, specific CTL response against tumour cells was significantly enhanced upon priming with irradiated LBC-transfected cells (27+2%) compared with irradiated LBC cells (15 + 1.5%) in a 4 h 5'Cr-release assay. It is suggested that neoexpression of MHC class II molecules enhances anti-tumour response by transforming tumour cells into professional antigen-presenting cells (APCs), which may be used to improve tumour-specific immunity in the autologous host.
The term immunosurveillance has been used to describe the concept of natural immunological host resistance against the development of cancer. According to Burnet's theory, primary immune system function is to recognise and destroy neoplastic cells before they grow and develop into a perceptible tumour (Burnet, 1970) .
Tumour cells which display immunogenic epitopes may evade immune detection by lacking the appropriate restriction components (Hammerling et al., 1987) . Cytotoxic T cells can recognise intracellular peptide antigens brought to the cell surface in conjunction with major histocompatibility complex (MHC) proteins (Tanaka et al., 1988) . As T cells recognise tumour-associated antigens in the context of MHC class I and II molecules, the ability to elicit an anti-tumour response is dependent not only on the presence of tumourassociated antigens but also on an appropriate presentation of these molecules (loannides and Whiteside, 1983; Kem et al., 1986) . The expression of MHC proteins on tumour cells may be critical for immunological recognition and tumour destruction.
The expression of MHC class II molecules on cells confers on them the ability to act as antigen presenting cells. In some autoimmune diseases, the abnormal expression of class II molecules allows the presentation of self antigens triggering an immune response directly against the aberrant tissue. This is the case for pancreatic fl-cells in certain types of diabetes (Bottazo et al., 1985) or for follicular cells in autoimmune thyroiditis (Londei et al., 1984) . On the other hand, it has been demonstrated that an enhanced expression of class II molecules in the cells of a murine L1210 lymphoma subpopulation likewise correlated with an increase in immunogenicity and decrease in tumorigenicity (Fuji and Iribe, 1986) .
Transfection of MHC genes has been used to study the effect on tumour cell growth in vivo as well as to induce a protective immune response against the tumour itself (Ostrand-Rosemberg et al., James et al., 1991) . Therefore, by inducing neoexpression of MHC class II antigens on neoplastic cells, antigen presentation could be enhanced thus improving anti-tumour immunity in syngeneic hosts.
In previous work we have reported the establishment and characterisation of the LBC cell line (Mongini et al., 1991) derived from the original T-cell leukaemia LB (Ruggiero et al., 1984) . LBC cells express the following surface markers: Thy-1, Lyt-2 (CD 8), CD 41ow+ CD 25 (IL-2 receptor, a chain), class I (Kd and Dd), but not class II (I-Ad, I-Ed) gene products. Although this cell line is tumorigenic in syngeneic mice, survival rate of mice inoculated with LBC cells is higher when compared with that of mice inoculated with LB cells. Furthermore, when compared with the original nonimmunogenic leukaemic cells, LBC induce a weak immune response in their syngeneic host (Mongini et al., 1995) .
Taking these findings into account and having demonstrated that LBC cells lack MHC class II antigens, grow aggressively in syngeneic hosts killing the animals in a relatively short time and induce a weak immune response, these cells provide a useful model for studying the relationships of class II molecules expression, immunogenicity and tumour development inter se.
Materials and methods

Mice
Two to four month old normal BALB/c mice were raised in the animal colony of the National Academy of Medicine, Buenos Aires, Argentina, and maintained on Cargill pellets and water ad libitum.
Tumour LB is a T-cell leukaemia, which spontaneously arose in a BALB/c mouse and has been maintained by serial passages in the peritoneal cavity of syngeneic hosts (Ruggiero et al., 1984; Alvarez et al., 1989; Lugasi et al., 1990) . LBC is an established cell line derived from LB leukaemia (Mongini et al., 1991) . It was maintained in RPMI-1640 (Gibco, Grand Island, New York, USA) supplemented with 10% heat inactivated FCS, 2 mM L-glutamine, 20 mM Hepes buffer, 100 jg ml-' penicillin, 150 ,ig ml-' streptomycin and 50 jgM 2-mercaptoethanol. Cells were used between passages 120 and 140.
Induction of MHC molecules by treatment with IFNs LBC cells (3 x 106 ml-') were incubated for 72 h at 37°C either with 20-1000 IU ml-' of IFNy (Genzyme, USA) or 20-1000 IU ml-' of IFNa+ / (Genzyme, USA) and expression of MHC class II molecules analysed by ELISA.
Cell ELISA This was carried out by the method described previously (Mongini et al., 1995) using 96-well flat bottom microtitre plates (NUNC, Denmark). Briefly, 3 x 10' LBC cells, LBCtransfected cells (LBCT) or macrophages were seeded into the wells and blocked with 1.5% BSA in TBS buffer (150 mM sodium chloride, 20 mM Tris-HCl; pH 7.4), centrifuged and the supernatant discarded. Cells were fixed with freshly prepared glutaraldehyde (0.25% in TBS) and neutralised with 100 mM glycine -1% BSA. Biotinylated monoclonal antibody clone 39-10-8 (specific for I-Ad molecules, Pharmingen) was added and incubated at 37°C for 1 h. Avidin-phosphataseconjugated (Biosys, Institute Pasteur, Paris) was used and the reaction developed by addition of freshly prepared pnitrophenylphosphate substrate (Sigma Chemical, St Louis, MO, USA). The reaction was stopped with 5 N sodium hydroxide and read for optical density at 405 nm in an automated ELISA reader (Dynatech, Denmark). Background absorbance was determined in control wells not treated with the first antibody but which had all the other reagents.
Flow cytometry LBC and LBC transfected cell suspensions (1.5 x 106) were washed in Hanks' solution containing 1% BSA and 0.1% sodium azide. Cells were stained with monoclonal antibody MKD6, specific for I-Ad (Kappler et al., 1981) or with a control isotyping antibody at 4°C for 30 min and, after washing, a second FITC-conjugated antibody was added and cells were left for an additional 30 min at 4°C. Cells were washed, fixed in paraformaldehyde and analysed by flow cytometry on a Becton Dickinson FACScan.
Isolation of eukaryotic DNA and DNA blot hybridisation DNA was isolated from LB, LBC and normal BALB/c splenocytes according to the method described by GrossBellard et al. (1973) with slight modifications. Digested DNA (10 jg) was electrophoresed through a 1% agarose gel and transferred to nylon membrane as described previously (Sambrook et al., 1989) . Hybridisation was carried out for 24 h at 60°C in 4xSSPE, 1% SDS, 0.001% PPi, 0.01 mg ml-' polyanetosulphonic acid (Sigma) and 100 jug ml-' denatured salmon sperm (Sigma) supplemented with random oligo-primed 32P-labelled probes specific for IAod and I-Afld antigens. These probes were kindly provided by L Hood (Steinmetz et al., 1982 (Steinmetz et al., , 1984 . Filters were washed twice at room temperature with 2 x SSC containing 0.5% SDS and twice at 60°C with 0.1 x SSC containing 0.5% SDS. Filters were exposed for 24-48 h at -70°C and developed.
DNA transfection LBC cells were tri-transfected using Lipofectin according to the procedure described by Dorman (Dorman, 1989) Swiss blast targets in a 4 h 5"Cr-release assay. A cytotoxicity of 10% or more was invariably statistically significant at P < 0.05 and was considered as being positive.
Tumour challenge experiments BALB/c mice were challenged with 1.0 x 106 or 1.0 x 103 viable LBCT and LBC cells. The mortality rate caused by tumour growth was recorded and differences were considered statistically significant at P < 0.05, by log-rank test (Peto et al., 1977) . DT50 represented the time at which 50% of challenged mice had died (Mongini et al., 1995) .
Statistical analysis All determinations were done in triplicate and statistical significance was established by Student's t-test for independent samples. Survival times were analysed with log-rank test (Peto et al., 1977) . Differences were considered statistically significant for P < 0.05.
Results
Southern blot analysis of LB and LBC (Ostrand-Rosemberg et al., 1990; James et al., 1991; Baskar et al., 1994 Baskar et al., , 1995 . Nevertheless, in these cases, tumour cells were already immunogenic in their syngeneic host, as derived from virus or chemically induced tumours, and the level of immunity generated with live transfected tumour cells might also be induced by non-transfected irradiated tumour cells alone as happens with some tumour cells engineered to secrete cytokines (Moudgil and Sercarz, 1994) . In our experimental model, a low number of different epitopes that stimulate antitumour response are restricted to a few molecules (Mongini et al., 1994) . Therefore, we suggest that the enhancement achieved in cellular immune response seems quantitative rather than qualitative, owing to clonal expansion of specific cytotoxic T lymphocytes and as a result of lymphokines synthesised by helper T lymphocytes that were stimulated directly by the tumour itself.
Concerted action by CD4+ and CD8+ T cells in successfully killing tumour cells has been demonstrated by gene transfection of neoplastic cells leading to the release of diverse helper cytokines (Fearon et al., 1990; Pardoll, 1993; Golumbek et al., 1991; Pippin et al., 1994 McKisic, et al., 1991; Dadmarz et al., 1995) led us to hypothesise on the intervention of these lymphocytes in conjunction with CD8+ on direct tumour cell lysis.
Our findings suggest that the induction of class II antigens expression provides an effective method to achieve an immunosurveillance status in cases where tumour cell number is low and metastasis is liable to develop after removal of the primary lesion. 
